In this webinar, Dr Ryan Paul diabetologist and endocrinologist overviews the role of dulaglutide, a subcutaneous once-weekly GLP-1 receptor agonist, in diabetes management.
Key topics include:
-When and how to use dulaglutide to treat type 2 diabetes.
-Advice on whether to choose funded dulaglutide or empagliflozin and when to consider switching between them.
-When to advise patients to self-fund dulaglutide if possible.
-How to reduce adverse effects of dulaglutide.
-The potential for dulaglutide to get patients off insulin and the role of dulaglutide in prevention of cardiovascular disease.
00:00 intro
00:30 Presentation by Dr Ryan Paul
48:00 Audience Poll questions
56:05 Audience Q&A
Goodfellow UnitGeneral PracticePrimary Health Care
![DMS X Nessie Judge – DMS [ Penelusuran ]](https://i.ytimg.com/vi/XB0xZx06Q3c/hqdefault.jpg)
0 Comments